Results 181 to 190 of about 13,874 (194)

A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis

New England Journal of Medicine, 2002
exaly  

Valganciclovir for Congenital Cytomegalovirus

New England Journal of Medicine, 2015
exaly  

Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation

American Journal of Transplantation, 2004
Todd Grazia, Mark R Nicolls
exaly  

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American Journal of Transplantation, 2007
exaly  

Valganciclovir

Reactions Weekly, 2013
openaire   +1 more source

Prevention of Posttransplant Cytomegalovirus Disease and Related Outcomes with Valganciclovir: A Systematic Review

American Journal of Transplantation, 2008
exaly  

Valganciclovir

Reactions Weekly, 2015
openaire   +1 more source

Valganciclovir in Patients with Glioblastoma

New England Journal of Medicine, 2013
exaly  

Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir

Clinical Infectious Diseases
Genovefa Anna Papanicolaou, Robin Avery, Johan A Maertens   +2 more
exaly  

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American Journal of Transplantation, 2010
exaly